A new paradigm in respiratory hygiene: Increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion

BMC Pulmonary Medicine

Volumn 5, Issue , 2005, Pages

  Zayas, Gustavo ^a   Dimitry, John ^a   Zayas, Ana ^a   O'Brien, Darryl ^a   King, Malcolm ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BORATE SODIUM; CALCIUM CHLORIDE; MUCIN;

AEROSOL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCUS; BRONCHUS SECRETION; CONTROLLED STUDY; COUGHING; FROG; MUCOCILIARY CLEARANCE; MUCOCILIARY TRANSPORT; NONHUMAN; PERSONAL HYGIENE; PROTEIN CROSS LINKING; SIMULATION; VISCOELASTICITY; VISCOSITY; AIR; ANIMAL; CHEMISTRY; HYGIENE; MUCUS; PALATE; PARTICLE SIZE; RANIDAE; RESPIRATORY TRACT DISEASE; THEORETICAL MODEL;

AEROSOLS; AIR MOVEMENTS; ANIMALS; COUGH; HYGIENE; MODELS, THEORETICAL; MUCUS; PALATE; PARTICLE SIZE; RANIDAE; RESPIRATORY TRACT DISEASES;

EID: 26844543606     PISSN: 14712466     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-5-11     Document Type: Article

References (22)

1. WHO: Global Defense against the Infectious Disease Threat. Edited by: Kindhauser MK. World Health Organization, Geneva; 2003.
2. WHO: Infectious disease report. World Health Organization, Geneva; 2002.
3. Somogyi R, Vesely AE, Azami T, Preiss D, Fisher J, Correia J, Fowler RA: Dispersal of respiratory droplets with open vs. closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome. Chest 2004, 125:1155-1157.
4. WHO: Influenza pandemic preparedness plan. The role of WHO and guidelines for national or regional planning. World Health Organization, Geneva; 1999.
5. WHO: Global Plan to Stop TB, Chapter 1, p 27, Stop TB Partnership. WHO, Geneva; 2001.
6. WHO: AntiTuberculosis Drug Resistance in the World. Report No 2: Prevalence and Trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2000.
7. Centers for Disease Control & Prevention: Improving Patient Adherence to Tuberculosis treatment (1994). National Center for HIV, STD and TB Prevention, Division of Tuberculosis Elimination; 2002.
8. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK: Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 2003, 58:525-527.
9. Duguid J: The numbers and sites of origin of the droplets expelled during respiratory activities. Edinburgh Med J 1945, 52:385.
10. Fennelly KP, Martyny JW: Isolation of viable airborne Mycobacterium tuberculosis: a new method to study transmission. Am J Respir Crit Care Med 1998, 157:A706.
11. King M, Rubin BK: Pharmacological approaches to discovery and development of new mucolytic agents. Advanced Drug Delivery Reviews 2002, 54:1475-1490.
12. King M, Rubin BK: Rheology of airway mucus: relationship with clearance function. In Chapter 7 of: Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion Edited by: Takishima T, Shimura S. New York: Marcel Dekker; 1994:283-314.
13. Clarke SW, King M: Respiratory defences: Physical defences. In Chapter 3.1 of: Respiratory Medicine 3rd edition. Edited by: Gibson CJ. London: Saunders; 2002:181-193.
14. Zayas JG, Rubin BK, York E, Lien D, King M: Bronchial mucus properties in lung cancer: relationship with site of lesion. Can Respir J 1999, 6:246-252.
15. King M, Brock G, Lundell C: Clearance of mucus by simulated cough. J Appl Physiol 1985, 58:1776-1782.
16. King M, Festa E: Evolution of the frog palate model for mucociliary clearance 1970-1997. In Cilia, Mucus, and Mucociliary Interactions Edited by: Baum GL. New York: Marcel Dekker; 1998:191-201.
17. Rubin B, Ramirez O, King M: Mucus-depleted frog palate as a model for the study of mucociliary clearance. J Appl Physiol 1990, 69:424-429.
18. Zayas G, Valle JC, Alonso M, Alfaro H, Vega D, Bonilla G, Reyes M, King M: A new paradigm in respiratory hygiene: modulators of airway secretions to improve clearance. Am J Respir Crit Care Med 2005, 171:. [2005 Am Thoracic Soc Conf (abstract)]
19. King M: Role of mucus viscoelasticity in cough clearance. Biorheology 1987, 24:589-597.
20. Verdugo P: Molecular biophysics of mucin secretion. In Chapter 3 of: Airway Secretion: Physiological Bases for the Control of Mucous Hypersecretion Edited by: Takashima T, Shimura S. New York: Marcel Dekker; 1994:101-121.
21. Rubin BK, van der Schans CP: Outcomes for trials of mucoactive therapy. In Therapy for Mucus-Clearance Disorders Edited by: Rubin BK, van der Schans CP. New York: Marcel Dekker; 2004:87-103.
22. Puchelle E, Zahm JM, Duvivier C: Spinnability of bronchial mucus: relationship with viscoelasticity and mucus transport properties. Biorheology 1983, 20:239-249.